| Track 1: General Virology and Basic Sciences |
| Track 1.1: Viral Genomics and Proteomics |
| Track 1.2: Viral Tropism and Transmission |
| Track 1.3: Cellular Factors Affecting Viral Replication and Pathogenicity |
| Track 1.4: Viral Replication Cycle |
| Track 2: Retrovirus-HIV/AIDS-Basic Sciences and Implications |
| Track 2.1: Immunology of HIV Infection |
| Track 2.2: Diagnostics and Prognostics of HIV Infections |
| Track 2.3: HIV-Associated Diseases |
| Track 2.4: Antiretroviral Therapies and Resistances |
| Track 2.5: AIDS Vaccines-New Approaches |
| Track 3: Clinical and Neuro Virology |
| Track 3.1: Clinical Viral Diagnostics |
| Track 3.2:
Vector and Blood born Diseases & Molecular Diagnosis of CNS Viral Infections |
| Track 3.3: Aging and Metabolic Syndromes of Neurologic Disorders by Viruses |
| Track 4: Respiratory and Emerging/Re-emerging Viruses |
| Track 4.1: Dengue Virus & Rubella virus |
| Track 4.2:
Influenza A (H1N1) Virus |
| Track 4.3:
Filoviruses- Ebola Virus, Westnile Viruses & Othomixovirus |
| Track 4.4: Herpes Viruses,Pox Viruses & Picorna Viruses |
| Track 5: Immuno Therapeutic Approaches for Viral Infections |
| Track 5.1: Viral Vectors for Gene Therapy |
| Track 5.2: Genetic Vaccines for Viral Infection |
| Track 5.3: Genetics : Viral diseases |
| Track 6: Human Tumor Virology |
| Track 6.1: Tumor Virology and Immunology |
| Track 6.2: Polyomavirus Infections Associated Cancer |
| Track 6.3: HPV Infection Associated Cervical Cancer |
| Track 6.4: Human T Cell Leukemia Virus Type 1 & Viral Oncoproteins |
| Track 6-5: Oncogenic Gamma herpes Viruses (KSHV & EBV) |
| Track 7: Antiviral Vaccine Development |
| Track 7.1: HCV, HIV, Avainflu, Influenza Vaccines and Cytomegalovirus Vaccines |
| Track 7.2: Virology, Immunology & Epidemology of Hepatitis Viruses |
| Track 8: Agriculture and Plant Virology |
| Track 8.1: Wheat and Rice Virus |
| Track 8.2: The Plant Virus Biodiversity, Ecology and Molecular Virology |
| Track 8.3: Viral Counter-Defense Proteins |
| Track 8.4: Viral Pathogen and Plant Disease Control |
| Track 9: Veterinary Virology |
| Track 9.1: Viral Molecular Diagnosis, Immunology and Vaccines development |
| Track 9.2: Host-Virus Interactions and Pathogenesis and Prion Disease |
| Track 9.3: Emerging Viruses and Zoonoses Epidemiology |
| Track 10: Pediatric Viral Infectious Diseases |
| Track 10.1: Viral Infections, Prevention and Treatment |
| Track 10.2: Respiratory Syncytial Virus Infection –Prevention |
| Track 10.3:
Rotavirus Vaccine and Children Diarrheal Prevention and Treatment |
| Track 11: Antiviral Drug Discovery and Development |
| Track 11.1: Drug Screening and Rational Drug Design |
| Track 11.2: Drug Design for HIV & HCV |
| Track 11.3: Anti Influenza, Avain flu, SARS Drug Discovery |
| Track 11.4: Nano Technology & Delivery Technologies for Antivirals |
| Track 12: Regulatory and Economical Aspects in Virology |
| Track 12.1: Virus Safety Risk Assessment |
| Track 12.2:
Virus Clearance Technologies to Address Current Needs in Biomanufacturing Facility Control and Protection |
| Track 12.3: Latest Developments in the Prophylactic and the Therapeutic Segment |
| Track 12.4: Optimizing Pre-clinical & Clinical Trials Performance |
| Track 12.5: Exploring the Future Potential of the Vaccine Market and Achieving Vaccine Manufacturing Excellence |
